Translate
Sunshine Biopharma Inc
About
Sunshine Biopharma Inc (NASDAQ:SBFM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 6 2026
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
Oct 28 2025
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
Oct 28 2025
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
Oct 20 2025
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
Oct 16 2025
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
Recent Videos
How to Invest in Sunshine Biopharma Inc (SBFM) Step by Step
Apr 12, 2026
My take on Sunshine Biopharma's 8-K: A necessary split?
Feb 25, 2026
My Insight on Sunshine Biopharma's Growth Plan (8-K)
Dec 17, 2025
TRADING UPSIDE : SBFM STOCK ANALYSIS | SUNSHINE BIOPHARMA INC STOCK
Nov 24, 2025
Financials
Revenue
$37.32 M
Market Cap
$5.1 M
P/E Ratio
0.20
EPS
5.31